subject area of
- Age-Related Characteristics and Outcomes of Patients With Heart Failure With Preserved Ejection Fraction Journal Articles
- Assessment of Long-Term Effects of Irbesartan on Heart Failure With Preserved Ejection Fraction as Measured by the Minnesota Living With Heart Failure Questionnaire in the Irbesartan in Heart Failure With Preserved Systolic Function (I-PRESERVE) Trial Journal Articles
- Baseline Plasma NT-proBNP and Clinical Characteristics: Results From the Irbesartan in Heart Failure With Preserved Ejection Fraction Trial Journal Articles
- Characterization of subgroups of heart failure patients with preserved ejection fraction with possible implications for prognosis and treatment response Journal Articles
- Chinese herbal medicine Shenzhuo Formula treatment in patients with macroalbuminuria secondary to diabetic kidney disease: study protocol for a randomized controlled trial Journal Articles
- Clinical Characteristics and Outcomes of Patients With Coronary Artery Disease and Angina Journal Articles
- Clinical and Echocardiographic Characteristics and Cardiovascular Outcomes According to Diabetes Status in Patients With Heart Failure and Preserved Ejection Fraction Journal Articles
- Clinical outcomes according to QRS duration and morphology in the irbesartan in patients with heart failure and preserved systolic function (I‐PRESERVE) trial Journal Articles
- Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial Journal Articles
- Developing and validating models to predict sudden death and pump failure death in patients with heart failure and preserved ejection fraction Journal Articles
- Effects of telmisartan, irbesartan, valsartan, candesartan, and losartan on cancers in 15 trials enrolling 138 769 individuals Journal Articles
- Factors Associated With Outcome in Heart Failure With Preserved Ejection Fraction Journal Articles
- Heart failure with preserved ejection fraction: Clinical characteristics of 4133 patients enrolled in the I‐PRESERVE trial Journal Articles
- International Geographic Variation in Event Rates in Trials of Heart Failure With Preserved and Reduced Ejection Fraction Journal Articles
- Irbesartan in Patients with Atrial Fibrillation Journal Articles
- Irbesartan in Patients with Heart Failure and Preserved Ejection Fraction Journal Articles
- Mode of Death in Patients With Heart Failure and a Preserved Ejection Fraction Journal Articles
- Monitoring the ACTIVE-W trial: Some issues in monitoring a noninferiority trial Journal Articles
- Mortality predictors and effects of antithrombotic therapies in atrial fibrillation: insights from ACTIVE-W Journal Articles
- Myocardial Infarction in Heart Failure With Preserved Ejection Fraction Journal Articles
- Predictors of Mortality in Patients With Atrial Fibrillation (from the Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events [ACTIVE A]) Journal Articles
- Prevalence and Significance of Alterations in Cardiac Structure and Function in Patients With Heart Failure and a Preserved Ejection Fraction Journal Articles
- Prior Pacemaker Implantation and Clinical Outcomes in Patients With Heart Failure and Preserved Ejection Fraction Journal Articles
- Prognostic Value of Baseline Plasma Amino-Terminal Pro-Brain Natriuretic Peptide and Its Interactions With Irbesartan Treatment Effects in Patients With Heart Failure and Preserved Ejection Fraction Journal Articles
- Prognostic Value of Insulin-Like Growth Factor-Binding Protein 7 in Patients with Heart Failure and Preserved Ejection Fraction Journal Articles
- Rationale and design of ACTIVE: The atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events Journal Articles
- Relation of Peripheral Collagen Markers to Death and Hospitalization in Patients With Heart Failure and Preserved Ejection Fraction Journal Articles
- Relationship Between Degree of Left Ventricular Dysfunction, Symptom Status, and Risk of Embolic Events in Patients With Atrial Fibrillation and Heart Failure Journal Articles
- Relationship between heart rate and mortality and morbidity in the irbesartan patients with heart failure and preserved systolic function trial (I‐Preserve) Journal Articles
- Risks and Benefits of Oral Anticoagulation Compared With Clopidogrel Plus Aspirin in Patients With Atrial Fibrillation According to Stroke Risk Journal Articles
- Sex Differences in Clinical Characteristics and Outcomes in Elderly Patients With Heart Failure and Preserved Ejection Fraction Journal Articles
- The Irbesartan in Heart Failure With Preserved Systolic Function (I-PRESERVE) Trial: Rationale and Design Journal Articles
- Worsening Renal Function and Outcome in Heart Failure Patients With Preserved Ejection Fraction and the Impact of Angiotensin Receptor Blocker Treatment Journal Articles